Catalyst Wire Dossier Catalyst Wire Dossier

tanespimycin

17-N-allylamino-17-demethoxygeldanamycin
Drug timelines are a Plus or Pro feature.

23 regulatory and trial events tracked for tanespimycin, covering 2011-05-30 to 2017-02-20. Get the full timeline:

Most recent: Clinical Trial Update: 17-AAG in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Previous Hormone Therapy [Phase 2]

See pricing